Scarica l'app Stockscreener
6.09
16.44%
0.86
Pre-mercato:
6.08
-0.010
-0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Precedente Chiudi:
$5.23
Aprire:
$5.25
Volume 24 ore:
93.53M
Relative Volume:
3.45
Capitalizzazione di mercato:
$2.60B
Reddito:
$64.60M
Utile/perdita netta:
$-377.75M
Rapporto P/E:
-3.929
EPS:
-1.55
Flusso di cassa netto:
$-335.64M
1 W Prestazione:
+19.41%
1M Prestazione:
+31.82%
6M Prestazione:
+53.40%
1 anno Prestazione:
-5.43%
Intervallo 1D:
$5.19
$6.30
Intervallo di 1 settimana:
$5.11
$6.30
Portata 52W:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Nome
Recursion Pharmaceuticals Inc
Settore
Industria
Telefono
(385) 269-0203
Indirizzo
41S RIO GRANDE STREET, SALT LAKE CITY
Confronta RXRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
6.09 | 2.28B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-03-16 | Iniziato | Needham | Buy |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-04 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | Iniziato | Berenberg | Buy |
| 2021-05-11 | Iniziato | BofA Securities | Buy |
| 2021-05-11 | Iniziato | Goldman | Neutral |
| 2021-05-11 | Iniziato | JP Morgan | Neutral |
| 2021-05-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
COST, AMD, RXRX, CIFR, SNOW: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - Fidelity
What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
Recursion Pharmaceuticals Shares Surge Amid Strategic Growth - TipRanks
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025 - ts2.tech
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory - Yahoo Finance
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know - Nasdaq
RXRX Shares Plunge: Time to Bail Out? - StocksToTrade
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
Can Recursion Pharmaceuticals Inc. recover in the next quarterJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
How to recover losses in Recursion Pharmaceuticals Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Recursion Pharmaceuticals Inc. still worth holding after the dip2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Will Recursion Pharmaceuticals Inc. stock recover faster than market2025 Big Picture & Entry and Exit Point Strategies - newser.com
Should you wait for a breakout in Recursion Pharmaceuticals Inc.Trade Entry Summary & Real-Time Buy Zone Alerts - newser.com
Biotech Stocks To Watch NowOctober 4th - MarketBeat
Why Recursion Pharmaceuticals (RXRX) Is Up 19.2% After Securing $12.5M Milestone in AI Drug Partnership - simplywall.st
Biotech Stocks To ResearchOctober 3rd - MarketBeat
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains? - Yahoo Finance
Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives - Yahoo Finance
Recursion Pharmaceuticals (RXRX): Assessing Valuation Following New Milestone Payment and Drug Development Progress - simplywall.st
Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionWeekly Profit Summary & Weekly Momentum Picks - newser.com
Published on: 2025-10-03 01:30:40 - newser.com
Published on: 2025-10-02 22:53:16 - newser.com
Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition - MSN
Best Biotech Stocks To Watch NowOctober 2nd - MarketBeat
Recursion Pharmaceuticals Inc. (RXRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
RXRX’s Market Moves: A Deep Dive - timothysykes.com
Recursion Pharmaceuticals’ Bold Strategy: A Gamechanger? - StocksToTrade
Recursion Pharmaceuticals Stock (RXRX) Opinions on $12.5M Milestone Payment - Quiver Quantitative
Published on: 2025-09-30 19:47:45 - newser.com
Jim Cramer on Recursion: “I Need to See a Proof of Concept Here” - MSN
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - AOL.com
Recursion Pharmaceuticals’ Recent Moves: What’s Next? - timothysykes.com
Recursion Pharmaceuticals’ Unexpected Surge - StocksToTrade
Recursion’s New Moves: Market Shake-Up? - timothysykes.com
Recursion Pharmaceuticals Inc Azioni (RXRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
4.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):